Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Q2 Revenues Up Slightly, Losses Widen

NEW YORK, Aug. 3, (GenomeWeb News) - Bruker Biosciences today reported increased revenues for the second quarter, amid widened net losses.

 

The Billerica, Mass., company reported $64.1 million in revenues for the quarter ended June 30, compared to $60.9 million for the comparable period last year. Losses totaled $4.7 million, or .05 per share, up from $1.6 million, or .02 per share, for the year-ago quarter.

 

The company warned of lower-than expected revenues for the quarter July 15.

 

R& D expenses increased to $10.9 million, compared to $9.7 million for the second quarter of 2003.

 

As of June 30, the company had $79.2 millon in cash and short-term investments, compared to $76.8 million as of December 31, 2003.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.